Author

Andrea E. Van Der Meulen - De Jong

ASSESSMENT OF COMORBIDITY AND PHYSICAL CAPACITY AS MARKERS FOR SAFETY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ASSESSMENT OF COMORBIDITY AND PHYSICAL CAPACITY AS MARKERS FOR SAFETY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Andrea E. Van Der Meulen - De Jong  et al.

INHIBITION OF PFKFB3 SUPPRESSES FIBROBLAST-MEDIATED INFLAMMATION IN INFLAMMATORY BOWEL DISEASE
INHIBITION OF PFKFB3 SUPPRESSES FIBROBLAST-MEDIATED INFLAMMATION IN INFLAMMATORY BOWEL DISEASE

Andrea E. Van Der Meulen - De Jong  et al.

STROMAL CELL SUBSETS SHOW MODEL-DEPENDENT CHANGES IN EXPERIMENTAL COLITIS AND AFFECT EPITHELIAL TISSUE REPAIR AND IMMUNE CELL ACTIVATION
STROMAL CELL SUBSETS SHOW MODEL-DEPENDENT CHANGES IN EXPERIMENTAL COLITIS AND AFFECT EPITHELIAL TISSUE REPAIR AND IMMUNE CELL ACTIVATION

Andrea E. Van Der Meulen - De Jong  et al.

IDENTIFICATION OF A DISTINCT MICROBIOTA SIGNATURE IN CROHN’S DISEASE-ASSOCIATED AND CRYPTOGLANDULAR PERIANAL FISTULAS
IDENTIFICATION OF A DISTINCT MICROBIOTA SIGNATURE IN CROHN’S DISEASE-ASSOCIATED AND CRYPTOGLANDULAR PERIANAL FISTULAS

Andrea E. Van Der Meulen - De Jong  et al.

RISK ASSESSMENT FOR POSTOPERATIVE RECURRENCE AFTER ILEOCOLONIC RESECTION IN CROHN'S DISEASE (ON BEHALF OF THE DUTCH INITIATIVE ON CROHN AND COLITIS (ICC)
RISK ASSESSMENT FOR POSTOPERATIVE RECURRENCE AFTER ILEOCOLONIC RESECTION IN CROHN'S DISEASE (ON BEHALF OF THE DUTCH INITIATIVE ON CROHN AND COLITIS (ICC)

Andrea E. Van Der Meulen - De Jong  et al.

SMOKING AND COLITIS-ASSOCIATED COLORECTAL NEOPLASIA: EXPLORING THE RELATIONSHIP
SMOKING AND COLITIS-ASSOCIATED COLORECTAL NEOPLASIA: EXPLORING THE RELATIONSHIP

Andrea E. Van Der Meulen - De Jong  et al.

POSTOPERATIVE PROPHYLACTIC THIOPURINES OR BIOLOGICALS ARE PROTECTIVE FOR CLINICAL AND ENDOSCOPIC RECURRENCE AT SHORT TERM FOLLOW-UP AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE, BUT NOT ASSOCIATED WITH A LONG-TERM BENEFICIAL EFFECT ON THE RISK OF
POSTOPERATIVE PROPHYLACTIC THIOPURINES OR BIOLOGICALS ARE PROTECTIVE FOR CLINICAL AND ENDOSCOPIC RECURRENCE AT SHORT TERM FOLLOW-UP AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE, BUT NOT ASSOCIATED WITH A LONG-TERM BENEFICIAL EFFECT ON THE RISK OF

Andrea E. Van Der Meulen - De Jong  et al.

USTEKINUMAB TROUGH CONCENTRATIONS ARE ASSOCIATED WITH BIOCHEMICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE
USTEKINUMAB TROUGH CONCENTRATIONS ARE ASSOCIATED WITH BIOCHEMICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE

Andrea E. Van Der Meulen - De Jong  et al.

TIME TRENDS FOR POSTOPERATIVE RECURRENCE AFTER ILEOCECAL RESECTION IN CROHN'S DISEASE: DETAILED EVALUATION OF ASSOCIATED FACTORS
TIME TRENDS FOR POSTOPERATIVE RECURRENCE AFTER ILEOCECAL RESECTION IN CROHN'S DISEASE: DETAILED EVALUATION OF ASSOCIATED FACTORS

Andrea E. Van Der Meulen - De Jong  et al.

HLA-DR+CD38+ EFFECTOR T HELPER CELLS DISTINGUISH CROHN’S DISEASE-ASSOCIATED PERIANAL FISTULAS FROM CRYPTOGLANDULAR FISTULAS
HLA-DR+CD38+ EFFECTOR T HELPER CELLS DISTINGUISH CROHN’S DISEASE-ASSOCIATED PERIANAL FISTULAS FROM CRYPTOGLANDULAR FISTULAS

Andrea E. Van Der Meulen - De Jong  et al.

THE EFFECT OF INDUCTION THERAPY WITH INFLIXIMAB OR VEDOLIZUMAB ON HEPCIDIN AND IRON STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
THE EFFECT OF INDUCTION THERAPY WITH INFLIXIMAB OR VEDOLIZUMAB ON HEPCIDIN AND IRON STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Andrea E. Van Der Meulen - De Jong  et al.

PREVALENCE OF IRON DEFICIENCY AND ANAEMIA IN THE OUTPATIENT INFLAMMATORY BOWEL DISEASE POPULATION: A DUTCH NATIONAL CROSS-SECTIONAL STUDY
PREVALENCE OF IRON DEFICIENCY AND ANAEMIA IN THE OUTPATIENT INFLAMMATORY BOWEL DISEASE POPULATION: A DUTCH NATIONAL CROSS-SECTIONAL STUDY

Andrea E. Van Der Meulen - De Jong  et al.

COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL
COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL

Andrea E. Van Der Meulen - De Jong  et al.

CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL
CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL

Andrea E. Van Der Meulen - De Jong  et al.

SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY
SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY

Andrea E. Van Der Meulen - De Jong  et al.

LOCALLY INJECTED ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS FOR THE TREATMENT OF REFRACTORY PROCTITIS: PRELIMINARY RESULTS OF A PHASE IIA TRIAL
LOCALLY INJECTED ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS FOR THE TREATMENT OF REFRACTORY PROCTITIS: PRELIMINARY RESULTS OF A PHASE IIA TRIAL

Andrea E. Van Der Meulen - De Jong  et al.

Item 1 - 16 / 16
1